BLVRA Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of BLVRA monoclonal antibodies for investigating biliverdin reductase A (BLVRA) in various biological processes. BLVRA monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). BLVRA is a key enzyme involved in the conversion of biliverdin to bilirubin, playing a crucial role in the body's antioxidant defense system. BLVRA functions in cellular protection against oxidative stress and has implications in various physiological and pathological conditions, including liver function and neuroprotection. Research focused on BLVRA can provide insights into potential therapeutic applications and disease mechanisms. BLVRA monoclonal antibodies enable precise detection and quantification in experimental studies. Investigating BLVRA expression patterns helps reveal its distribution across different tissues and cell types. Understanding BLVRA regulation mechanisms can illuminate its role in cellular signaling pathways. Santa Cruz Biotechnology monoclonal antibodies for BLVRA support researchers worldwide in advancing scientific knowledge of cellular defense mechanisms and disease pathways.